EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

What Is—and What Is Not—Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls

Diego Liviu Boaru iD, Oscar Fraile-Martinez iD, Patricia De Castro-Martinez iD, Miguel A Ortega iD, Cielo Garcia-Montero iD

International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3061

DOI: 10.3390/ijms27073061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Diego Liviu Boaru und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Medical Specialties, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas (CIBEREHD), Fa…. Hauptthemen laut MEDLINE: Immunogenic Cell Death, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: COMUNIDAD DE MADRID, Comunidad de Madrid https://ror.org/040scgh75, ProACapital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immunogenic cell death (ICD) links tumor cell demise to the activation of anti-tumor immunity, but its adoption has also generated inconsistent definitions and frequent overinterpretation of surrogate biomarkers. Here, we synthesize mechanistic and methodological evidence showing that danger-associated molecular patterns (DAMPs), cytokine release, and endoplasmic reticulum stress report immunogenic potential rather than ICD itself. We propose that ICD should be defined by its functional immunological endpoint, namely efficient antigen presentation and antigen-specific adaptive immunity, ideally culminating in protective immunological memory. To operationalize this principle, we introduce a hierarchy of experimental validation ranging from correlative hallmarks (Level 0) to innate immune integration (Level 1), antigen-specific T-cell priming (Level 2), definitive vaccination-rechallenge protection with immune-dependence testing (Level 3), and translational relevance supported by convergent human data (Level 4). We also discuss common pitfalls, equating inflammation, necrosis-associated DAMP release, or therapeutic benefit with ICD, and outline minimal immune-context controls (e.g., MHC-I, CD8+ T cells, Batf3-dependent dendritic cells, and innate sensing pathways) required to support robust claims. Finally, we highlight why ICD remains strongly context-dependent, shaped by dendritic-cell competence, innate licensing, purinergic metabolism, and microenvironmental constraints. Evidence-graded standards should improve reproducibility, strengthen peer review, and accelerate clinically meaningful ICD-based strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunogenic Cell DeathNeoplasmsHumansAnimalsDendritic CellsImmunity, InnateAlarminsAntigen Presentation

Stichwörter der Autor:innen

CD8+ T cellsantigen presentationdamage-associated molecular patterns (DAMPs)dendritic cellsimmunogenic cell deathtumor microenvironment

Substanzen

Alarmins

Autor:innen und Institutionen

  • Department of Medicine and Medical Specialties, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas (CIBEREHD), Faculty of Medicine and Health Sciences, University of Alcalá, 28801 Alc…
  • Ramón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain.

ORCID-Profile: Diego Liviu Boaru, Oscar Fraile-Martinez, Patricia De Castro-Martinez, Miguel A Ortega, Cielo Garcia-Montero

Förderung

  • COMUNIDAD DE MADRID
  • Comunidad de Madrid https://ror.org/040scgh75
  • ProACapital
  • HALEKULANI, S. L.
  • MJR

Zitieren

APA

Boaru, D. L., Fraile-Martinez, O., De Castro-Martinez, P., Ortega, M. A., & Garcia-Montero, C. (2026). What Is—and What Is Not—Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls. International Journal of Molecular Sciences, 27(7), 3061. https://doi.org/10.3390/ijms27073061

Vancouver

Boaru DL, Fraile-Martinez O, De Castro-Martinez P, Ortega MA, Garcia-Montero C. What Is—and What Is Not—Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls. International Journal of Molecular Sciences. 2026;27(7):3061. doi:10.3390/ijms27073061

BibTeX
@article{Boaru2026,
  author = {Boaru, Diego Liviu and Fraile-Martinez, Oscar and De Castro-Martinez, Patricia and Ortega, Miguel A and Garcia-Montero, Cielo},
  title = {What Is—and What Is Not—Immunogenic Cell Death? Functional Definitions, Experimental Standards, and Common Pitfalls},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {7},
  pages = {3061},
  doi = {10.3390/ijms27073061}
}
Kostenlos starten →